NRXP · Company research
NRX Pharmaceuticals, Inc. Common Stock (NRXP): Stock News & Events
Recent company-linked news records available in the database.
RESEARCH CONTEXT
Understand the numbers
Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.
18records availableHealthcare
Stock News & Events data
Database-backed records only
| title | summary | url | source | published at | sentiment | sentiment score | relevance score |
|---|---|---|---|---|---|---|---|
| NRx Pharmaceuticals, Inc. (NRXP) Stock Price, News, Quote & History - Yahoo! Finance Canada | NRx Pharmaceuticals, Inc. (NRXP) Stock Price, News, Quote & History Yahoo! Finance Canada | View source ↗ | Yahoo! Finance Canada | Oct 16, 2026 | neutral | 0 | 0.6 |
| NRx Pharmaceuticals, Inc. (NRXP) stock price, news, quote and history - Yahoo Finance UK | NRx Pharmaceuticals, Inc. (NRXP) stock price, news, quote and history Yahoo Finance UK | View source ↗ | Yahoo Finance UK | Oct 15, 2026 | neutral | 0 | 0.6 |
| FDA asks NRx to send labels showing the proposed name for its preservative-free ketamine - Stock Titan | FDA asks NRx to send labels showing the proposed name for its preservative-free ketamine Stock Titan | View source ↗ | Stock Titan | Oct 15, 2026 | neutral | 0 | 0.6 |
| FDA Showdown Week: CAPR, NRXP, REPL And MRNA Face Make-Or-Break Regulatory Decisions - Stocktwits | FDA Showdown Week: CAPR, NRXP, REPL And MRNA Face Make-Or-Break Regulatory Decisions Stocktwits | View source ↗ | Stocktwits | Oct 12, 2026 | neutral | 0 | 0.6 |
| NRx Pharmaceuticals Lands DARPA Contract for SPARC-TMS Trial - The Globe and Mail | NRx Pharmaceuticals Lands DARPA Contract for SPARC-TMS Trial The Globe and Mail | View source ↗ | The Globe and Mail | Oct 6, 2026 | neutral | 0 | 0.6 |
| A trial will test a one-day course of brain stimulation and a drug for depression - Stock Titan | A trial will test a one-day course of brain stimulation and a drug for depression Stock Titan | View source ↗ | Stock Titan | Sep 30, 2026 | neutral | 0 | 0.6 |
| NRXP Should I Buy - Intellectia AI | NRXP Should I Buy Intellectia AI | View source ↗ | Intellectia AI | Sep 26, 2026 | neutral | 0 | 0.6 |
| NRx Pharmaceuticals (NASDAQ:NRXP) Is In A Good Position To Deliver On Growth Plans - Simply Wall Street | NRx Pharmaceuticals (NASDAQ:NRXP) Is In A Good Position To Deliver On Growth Plans Simply Wall Street | View source ↗ | Simply Wall Street | Sep 25, 2026 | neutral | 0 | 0.6 |
| A protein found in more than 75% of people with ALS may damage nerves. GeNeuro wins a patent for an antibody targeting it. - Stock Titan | A protein found in more than 75% of people with ALS may damage nerves. GeNeuro wins a patent for an antibody targeting it. Stock Titan | View source ↗ | Stock Titan | Sep 14, 2026 | neutral | 0 | 0.6 |
| Five million ketamine doses are in production—but when can sales start? - Stock Titan | Five million ketamine doses are in production—but when can sales start? Stock Titan | View source ↗ | Stock Titan | Aug 17, 2026 | neutral | 0 | 0.6 |
| NRx Pharmaceuticals, Inc. (NRXP) Reports Q2 Loss, Misses Revenue Estimates - Yahoo Finance | NRx Pharmaceuticals, Inc. (NRXP) Reports Q2 Loss, Misses Revenue Estimates Yahoo Finance | View source ↗ | Yahoo Finance | Aug 14, 2026 | neutral | 0 | 0.6 |
| NRx to Discuss Preservative-Free Ketamine Approval Path Aug. 10 - Stock Titan | NRx to Discuss Preservative-Free Ketamine Approval Path Aug. 10 Stock Titan | View source ↗ | Stock Titan | Aug 7, 2026 | neutral | 0 | 0.6 |
| A vial used in products that shipped 11.9M doses remains in NRx's FDA review - Stock Titan | A vial used in products that shipped 11.9M doses remains in NRx's FDA review Stock Titan | View source ↗ | Stock Titan | Aug 7, 2026 | neutral | 0 | 0.6 |
| FDA Showdown Week: CAPR, NRXP, REPL And MRNA Face Make-Or-Break Regulatory Decisions - TradingView | FDA Showdown Week: CAPR, NRXP, REPL And MRNA Face Make-Or-Break Regulatory Decisions TradingView | View source ↗ | TradingView | Jul 24, 2026 | neutral | 0 | 0.6 |
| Market Sentiment Around Loss-Making NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) - Simply Wall Street | Market Sentiment Around Loss-Making NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Simply Wall Street | View source ↗ | Simply Wall Street | Jul 16, 2026 | neutral | 0 | 0.6 |
| Is NRx Pharmaceuticals, Inc. (NRXP) Stock Positioned for Growth Through Depression and PTSD Treatment Innovation? - Yahoo Finance | Is NRx Pharmaceuticals, Inc. (NRXP) Stock Positioned for Growth Through Depression and PTSD Treatment Innovation? Yahoo Finance | View source ↗ | Yahoo Finance | Jul 15, 2026 | neutral | 0 | 0.6 |
| NRx Pharmaceuticals (NRXP) Closes Underwritten Public Offering of Common Stock At $3.50 Per Share - Yahoo Finance | NRx Pharmaceuticals (NRXP) Closes Underwritten Public Offering of Common Stock At $3.50 Per Share Yahoo Finance | View source ↗ | Yahoo Finance | Jun 10, 2026 | neutral | 0 | 0.6 |
| Here is why NRx Pharmaceuticals, Inc. (NRXP) is among the Best Rated Penny Stocks to Buy According to Wall Street Analysts - Yahoo Finance | Here is why NRx Pharmaceuticals, Inc. (NRXP) is among the Best Rated Penny Stocks to Buy According to Wall Street Analysts Yahoo Finance | View source ↗ | Yahoo Finance | May 24, 2026 | neutral | 0 | 0.6 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.